Document is current
Any future updates will be listed below
-
Authors
Wang, Tao
Wu, Guodong
Gao, Peigen
Zhuang, Fenghui
Wang, Zeyu
Zhou, Ziheng
Li, Chongwu
Wu, Junqi
Zhao, Deping
-
Funding
Funding for this research was provided by:
Shanghai Municipal Hospital Development Center (SHDC22024308)
National Science and Technology Major Project of China (2024ZD0529006)
- License Information
-
More Information
Article History
Received: 27 August 2025
Accepted: 23 January 2026
First Online: 9 February 2026
Declarations
:
: Approval for all animal experiments was granted by the Animal Care and Use Committee of Shanghai Pulmonary Hospital (FKDS-22-1-067, 2022/01/16) named Study of MSC-EVs alleviating pulmonary ischemia and reperfusion, adhering to the Guide for the Institutional Animal Care and Use Committee (IACUC). MSC-EVs were purchased from Cellular Biomedicine Group (CBMG, Shanghai, China). According to the provider, all MSCs were originally collected under protocols approved by the local Institutional Review Board, and written informed consent was obtained from all donors at the time of tissue collection. Public information on the ethical sourcing of these MSCs is available on the company’s website ( ) and in previous publications [ ].
: All authors consent for Publication.
: The authors declare no competing interests.
